AIHealthcare

Persist AI is a privately held biotechnology and pharmaceutical-technology company developing AI- and robotics-enabled tools for drug formulation and manufacturing. Its platform combines machine learning, automated high-throughput experimentation, robotic laboratories, automated drug-release testing, and formulation analytics to accelerate development of long-acting injectable and other extended-release medicines. The company says its approach can reduce formulation-development timelines by approximately 30–50%; it launched a Cloud Lab platform and is deploying a cGMP-compatible manufacturing line to support pharmaceutical customers. Its market position is as an early-stage specialist at the intersection of AI, laboratory automation, drug delivery, and pharmaceutical CMC, rather than as a clinical-care or diagnostic AI company.